Print Page      Close Window     

2019 Press Releases

Keyword Search
 
February 1, 2019
Iovance Biotherapeutics to Present at Upcoming Investor and Medical Conferences
SAN CARLOS, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the company will participate and present at the following upcoming conferences: 5th Annual Immuno-Oncology 360° conference in New York, February 6-8, 2019 Presenter: Maria Fardis, Ph.D., President and Chief Executive Officer Session: Next Generati... More »